Cluster Headache and Related ConditionsJes Olesen, Peter J. Goadsby Oxford University Press, 1999 - 309 Seiten Cluster headache affects 0.1% of the population and is a severe form of primary headache. This volume of Frontiers in Headache Research is the only up-to-date and comprehensive review of the condition and its related disorders. The book begins with a discussion of the basic circadian biology of the condition followed by an overview of relevant epidemiological studies. Cluster headache is then described in comparison with related disorders, including paroxysmal hemicrania, SUNCT, hemicrania continua and hypnic headache, and the system of classification discussed. The volume then moves on to look at the wealth of basic research into cluster headache, including, animal studies, work on the autonomic nervous system in man, neuropeptide research, studies of biological rhythms, the associated endocrinology, information derived from neuroimaging and the influence of genetic factors. The final sections of the book examine acute treatment, prophylaxis, the potential for surgical treatment and the opportunities for further innovative therapies. The contributing authors are all international specialists in this field. |
Inhalt
a clinical and pathophysical overview | 13 |
Paroxysmal hemicrania | 27 |
differences in age | 42 |
Urheberrecht | |
31 weitere Abschnitte werden nicht angezeigt.
Häufige Begriffe und Wortgruppen
ache activation acute artery associated autonomic blood brain central Cephalalgia changes chronic cluster headache Chronic paroxysmal hemicrania circadian Classification clinical cluster headache attacks cluster headache patients cluster period compared complete continua controls cranial criteria Department developed diagnosis discussed disease disorder dose drug duration effect Ekbom episodic cluster headache ergotamine et al facial factors female findings frequency function head Headache Society hormone hypothalamic increased indomethacin injection involved Italy Journal least levels light male mean mechanisms medication melatonin migraine nasal nerve neuralgia Neurology normal observed occur onset oxygen pain pattern phase placebo possible present primary prophylactic receptor reduced References relief remission reported Research response rhythm severe showed side significant Sjaastad sleep stimulation subjects sufferers suggest sumatriptan SUNCT sweating sympathetic symptomatic symptoms syndrome Table treatment trials trigeminal unilateral University usually vascular verapamil
Verweise auf dieses Buch
Paroxysmale Störungen in der Neurologie Bettina Schmitz,Barbara Tettenborn Keine Leseprobe verfügbar - 2004 |